Point72 Asset Management, L.P.
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 1603466
STAMFORD, CT
Position in SNDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$46,382,377
-$56,189,556 QoQ
Shares Held
1,985,547
-59.3% QoQ
Ownership
2.22%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Derivatives in SNDX
reported options exposure · as of Mar 31, 2025CallValue
$2,457,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in SNDX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,382,377 | 1,985,547 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $102,571,933 | 4,882,053 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $65,463,898 | 4,255,047 | Shares | Defined | 2025-11-14 | |
| 2025-08-15 | $68,121,964 | 4,327,952 | Shares | Sole | 2025-08-18 | |
| 2025-06-30 | $21,612,771 | 2,307,824 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $19,923,728 | 2,127,467 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $49,246,879 | 4,008,700 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $2,457,000 | 200,000 | Call | Defined | 2025-07-21 | |
| 2025-01-21 | $58,478,168 | 4,277,847 | Shares | Sole | 2025-01-22 | |
| 2024-12-31 | $25,326,029 | 1,915,736 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $1,737,108 | 131,400 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $53,481,639 | 2,778,267 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $57,131,972 | 2,782,853 | Shares | Defined | 2024-09-16 | |
| 2024-06-30 | $1,283,125 | 62,500 | Call | Defined | 2024-09-16 | |
| 2024-03-31 | $49,187,103 | 2,066,685 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $61,253,523 | 2,834,499 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $30,407,798 | 2,094,201 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $25,844,364 | 1,234,800 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,075,328 | 524,400 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $23,500,530 | 923,400 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $6,256,800 | 360,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,729,359 | 353,100 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,807,799 | 460,900 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,363,908 | 312,400 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $21,170,448 | 946,800 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $25,440,336 | 1,143,900 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,450,706 | 166,037 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||